KYNZIE OLIVER: Open Payments
NPI 1346799400 · WILLISTON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 57 payments from 9 companies in 2025. Trend: 2023 $623 · 2024 $811 · 2025 $972
Food & beverage: $872Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $413 |
| Janssen Biotech, Inc. | 5 | $140 |
| Lilly USA, LLC | 4 | $89 |
| GENZYME CORPORATION | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 5 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| UCB, Inc. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, TALTZ, COSENTYX, RINVOQ, Bimzelx, NEMLUVIO.
Industry payments across ND — which companies pay providers there.
